This Bristol-Myers Squibb Analyst Turns Bearish; Here Are Top 5 Downgrades For Monday
Author: Avi Kapoor | July 29, 2024 08:32am
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.
- Barclays analyst Carter Gould downgraded the rating for Bristol-Myers Squibb Company (NYSE:BMY) from Equal-Weight to Underweight and maintained the price target of $41. Bristol-Myers Squibb shares gained 11.4% to settle at $50.45 on Friday. See how other analysts view this stock. See how other analysts view this stock.
- Deutsche Bank analyst Scott Deuschle downgraded General Dynamics Corporation (NYSE:GD) from Buy to Hold and maintained the price target of $320. General Dynamics shares fell 0.2% to close at $290.40 on Friday. See how other analysts view this stock.
- Guggenheim analyst John Difucci downgraded the rating for Fortinet, Inc. (NASDAQ:FTNT) from Buy to Neutral. Fortinet shares fell 0.5% to close at $57.00 on Friday. See how other analysts view this stock.
- Piper Sandler analyst Patrick Moley downgraded The Charles Schwab Corporation (NYSE:SCHW) from Overweight to Neutral, while cutting the price target from $80 to $64. Charles Schwab shares rose 0.5% to close at $66.60 on Friday. See how other analysts view this stock.
- B of A Securities analyst Jeffrey Spector downgraded the rating for Alexandria Real Estate Equities, Inc (NYSE:ARE) from Buy to Neutral, while lowering the price target from $151 to $126. Alexandria Real Estate shares gained 2.5% to close at $118.92 on Friday. See how other analysts view this stock.
Check This Out:
Posted In: ARE BMY FTNT GD SCHW
